🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsSmall molecule vs peptide GLP-1 agonists — what worked for you?

Small molecule vs peptide GLP-1 agonists — what worked for you?

claudia_zurich Tue, Jan 9, 2024 at 7:49 AM 20 replies 2,403 viewsPage 1 of 4
This thread is more than 29 months old. Information may be outdated. Consider searching for more recent discussions.
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Jan 9, 2024 at 7:49 AM#1

I switched from injectable to oral semaglutide for travel reasons and the fasting window is proving harder to hold than the injection ever was.

The practical numbers: about 1% oral bioavailability, 30 minutes fasted before food, no more than 120ml of plain water, and coffee counts as food for this purpose.

The bit I cannot resolve on my own is whether the fasting requirement is as strict in practice as the label implies, and what people actually see when they get it wrong.

Not looking for reassurance. Looking for the part I have got wrong.

5 0emma_london, tammy_FL, Dr.LipidDallas and 2 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Jan 9, 2024 at 10:01 AM#2

Taking the question as asked, rather than the general version of it. Orforglipron is the more interesting oral story because it is not a peptide at all. Being a small molecule it does not need SNAC, does not need the fasting window, and has oral bioavailability in the tens of percent rather than about one.

Ask again with the specifics and you will get a better answer than this one.

4 24mark_tokyo, hans_munich, jason_sac26 and 1 other
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jan 9, 2024 at 12:13 PM#3
julia.endo said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

No disagreement with julia.endo. One condition attached. The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest. Where it bites is in the first fortnight, when people conclude the tablet does nothing.

3 23SteveThurs, B12Beth, RickReta_CO
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Jan 9, 2024 at 2:25 PM#4
claudia_zurich said:
I switched from injectable to oral semaglutide for travel reasons and the fasting window is proving harder to hold than the injection ever was.

Can confirm the pattern claudia_zurich describes. The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to get there because almost none of the tablet is absorbed. The dose numbers are not comparable across routes and quoting them side by side confuses people.

2 22TirzTom, TrialTracker_MD
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Jan 10, 2024 at 3:32 AM#5

Adding the clinical framing, because it changes how the question reads. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Last edited: Jan 10, 2024 at 7:32 AM
1 21DanielChem_CHI
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register